IMUXIMMUNIC, INC.vs its industry peers
A metric-by-metric comparison of IMMUNIC, INC. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IMUX본 종목 | $138M#4 | 5.0x#1 | 1.1x#3 | — | — | 3.3%#3 | — | -76.2%#5 | — | — | 23.9%#1 | — |
| RNA | $163M#1 | — | 0.8x#2 | — | — | — | — | 0.0%#2 | — | — | — | — |
| CNTN | $162M#2 | — | 0.4x#1 | — | — | -194.5%#4 | — | -7.9%#3 | — | — | — | — |
| LFCR | $158M#3 | — | — | 1.2x#1 | 0.5%#1 | -422.5%#5 | -13.4%#1 | — | -28.7%#1 | 3#1 | — | — |
| UNCY | $133M#5 | — | 2.5x#4 | 196.8x#2 | -29.0%#2 | 27.7%#1 | -4372.9%#3 | -49.8%#4 | — | — | — | — |
| MNOV | $123M#6 | — | 3.3x#5 | 300.4x#3 | — | 8.6%#2 | -3242.5%#2 | 32.2%#1 | — | — | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-09-17.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice